文献速递核素与放射性配体治疗肿瘤 PET/CT

核医学产学研合作:2024年CMIIT产业合作伙伴圈会议纪要

Industry-Academic Collaboration in Nuclear Medicine: Proceedings from the 2024 CMIIT Industry Partners Circle.
PubMed 文献 · J Nucl Med · 2026-09-02

本文总结2024年1月由CMIIT主办的产业合作伙伴圈(IPC)会议讨论,参会者包括SNMMI staff与领导层、CMIIT理事会成员、学术界关键利益相关方及生物制药与设备制造企业代表。会议聚焦转化社区的4项优先事项:壮大人才梯队、改进产学研合作以支持职业发展、促进放射性药物临床试验、克服α疗法开发障碍。

要点

  • 会议聚焦4项转化优先事项:人才梯队、产学研职业发展合作、放射性药物临床试验、α疗法开发障碍。
  • IPC为SNMMI每两年举办一次的产学研对话机制,2024年会议由CMIIT主办。
  • 参会方涵盖SNMMI、CMIIT理事会、学术界及生物制药和设备制造企业代表。

核心结论

  • 推动和简化诊疗一体化放射性药物的开发管线与转化,需要SNMMI、产业伙伴与学术界持续跨部门合作,以保障持续增长、创新与临床转化。

研究设计与样本

  • 本文为2024年1月CMIIT主办的IPC会议纪要,参会者包括SNMMI staff与领导层、CMIIT理事会成员、学术界关键利益相关方及多家生物制药公司与设备制造商代表。

主要发现

  • 2024年CMIIT IPC旨在应对转化社区浮现的4项关键优先事项:壮大人才梯队、改进产学研合作以支持职业发展、促进放射性药物临床试验、克服α疗法开发障碍。

临床怎么用

  • 可依据会议提出的4项优先事项,在人才梯队、产学研职业发展合作、放射性药物临床试验和α疗法开发方面推动跨部门协作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Advancing and streamlining the development pipeline and translation of theranostic radiopharmaceuticals for application in nuclear medicine necessitates continued cross-sector collaboration among key stakeholders from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), industry partners, and academics to ensure continued growth and innovation and clinical translation. One mechanism the SNMMI has for such dialogue is its biennial Industry Partners Circle (IPC). After the success of prior IPCs, the Center for Molecular Imaging, Innovation, and Translation (CMIIT) hosted the latest IPC in January 2024. The goals of the 2024 CMIIT IPC were to address 4 key priorities that have emerged for the translational community: grow the workforce pipeline, improve academia/industry collaborations to support career development, facilitate radiopharmaceutical clinical trials, and overcome barriers in developing α-therapies. The IPC was attended by SNMMI staff and leadership, members of the CMIIT board of directors, key stakeholders from academia, and industry representatives from a broad range of biopharmaceutical companies and equipment manufacturers. This article summarizes the discussions that were conveyed at the 2024 CMIIT IPC.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Osborne D, Cutler CS, Chaple IF, et al. Industry-Academic Collaboration in Nuclear Medicine: Proceedings from the 2024 CMIIT Industry Partners Circle. J Nucl Med. 2026. PMID: 42209122. doi:10.2967/jnumed.126.272619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。